About
Thibaut De Smedt is a former Amgen and Addex R&D scientist who brings a drug-discovery–first, deeply technical approach, serial company founding experience and hands-on managing-director roles in portfolio companies.
Invests in
BiotechHealthtechMedical Devices
Investments
Led
AiDDDepth ChargeImmuthesKliRNAxSeedD
Investor
Cosmyc TherapeuticsEthyrealPetalion Therapeutics
Per the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Thibaut De Smedt?
- Thibaut De Smedt is a former Amgen and Addex R&D scientist who brings a drug-discovery–first, deeply technical approach, serial company founding experience and hands-on managing-director roles in portfolio companies.
- Where does Thibaut De Smedt work?
- Thibaut De Smedt is Venture Partner at Medicxi.
- What does Thibaut De Smedt invest in?
- Thibaut De Smedt invests in Biotech, Healthtech, Medical Devices.
- What companies has Thibaut De Smedt invested in?
- Investments tracked here include AiDD, Depth Charge, Immuthes, KliRNA, xSeedD, Cosmyc Therapeutics, Ethyreal, Petalion Therapeutics.
- Does Thibaut De Smedt lead rounds?
- Yes — Thibaut De Smedt has led 5 tracked investments.